Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback (NF-Agency)

March 21, 2022 updated by: Giuseppe Angelo Zito, ETH Zurich
This study investigates whether the sense of agency is sensitive to self-regulation by means of EEG-based neurofeedback. During neurofeedback, the brain activity in response to a motor task is recorded in real-time and displayed back to the participants. The participants can therefore use this information to adapt their performance on the motor task.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

225

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria (all):

  • Aged > 18 years old
  • Normal or corrected-to-normal visual acuity
  • Willing to participate in the study (by signing the informed consent form)
  • Neither caffein, nor alcohol intake 48 hours prior to the experiment
  • Regular intake of drugs (except oral contraceptives in women)
  • Employed by, or in a dependent relationship with, the sponsor and / or the investigator(s)
  • Sufficient knowledge of German or English to understand study documents and instructions.

Inclusion Criteria (patients):

  • A diagnosis of temporal epilepsy (TE), documented via video EEG. OR
  • A diagnosis of psychogenic non-epileptic seizure (PNES), according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), and documented via video EEG.

Exclusion Criteria (all):

  • Past surgery in the brain
  • History of alcohol or drug abuse
  • Incompatibility with EEG recordings, e.g., inability to stay seated for 90 minutes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Real neurofeedback
The first arm will receive real neurofeedback.
During neurofeedback, the brain activity in response to a motor task is recorded in real-time and displayed back to the participants.
Sham Comparator: Sham neurofeedback
The second arm will receive sham neurofeedback.
During sham neurofeedback, a signal which resembles the participant's brain activity is used instead of the actual brain activity.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Electrophysiological data, i.e., EEG power in alpha band
Time Frame: Before and immediately after neurofeedback
Brain activity
Before and immediately after neurofeedback
Change in Electrophysiological data, i.e., EEG power in theta band
Time Frame: Before and immediately after neurofeedback
Brain activity
Before and immediately after neurofeedback
Change in Electrophysiological data, i.e., EEG power in gamma band
Time Frame: Before and immediately after neurofeedback
Brain activity
Before and immediately after neurofeedback
Change in the subjective perception of the Sense of Agency, i.e., visual analog scale assessing how much control participants feel over the game
Time Frame: Before and immediately after neurofeedback
Behavioural performance in response to manipulation of the Sense of Agency (SoA)
Before and immediately after neurofeedback

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age in years
Time Frame: Before neurofeedback
Baseline variable
Before neurofeedback
Sex (male/female)
Time Frame: Before neurofeedback
Baseline variable
Before neurofeedback
Years of education
Time Frame: Before neurofeedback
Baseline variable
Before neurofeedback
Medication status
Time Frame: Before neurofeedback
Baseline variable, list of drugs currently in use by the participant
Before neurofeedback
Anxiety
Time Frame: Before neurofeedback
Baseline variable assessed with the State-Trait Anxiety Inventory (STAI). Minimum value (20) = no anxiety. Maximum value (80) = high anxiety.
Before neurofeedback
Mood
Time Frame: Before neurofeedback
Baseline variable assessed with a visual analog scale. Minimum value (0) = bad mood. Maximum value (100) = good mood.
Before neurofeedback
Sleep habits
Time Frame: Before neurofeedback
Baseline variable assessed with the Pittsburgh Sleep Quality Index (PSQI). Minimum value (0) = good sleep quality. Maximum value (20) = poor sleep quality.
Before neurofeedback
Daily rate of cigarettes
Time Frame: Before neurofeedback
Baseline variable assessed in number of cigarettes/day
Before neurofeedback

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Anticipated)

January 31, 2025

Study Completion (Anticipated)

January 31, 2025

Study Registration Dates

First Submitted

November 30, 2021

First Submitted That Met QC Criteria

January 17, 2022

First Posted (Actual)

January 31, 2022

Study Record Updates

Last Update Posted (Actual)

April 1, 2022

Last Update Submitted That Met QC Criteria

March 21, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health, Subjective

Clinical Trials on Real Neurofeedback

Subscribe